Neurobiology of Opioid Dependence: 5 - 5

Yale University

Status and phase: Withdrawn; Phase 2

Conditions: Opioid-Related Disorders

Treatments: Drug: Naltrexone

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000196

NIDA-00191-5

K20-00191-5

K20DA000191 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to determine the effect of acute naltrexone pretreatment on the response to yohimbine in healthy volunteers.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.